HCA Healthcare, Inc.
HCA
$321.75
$2.120.66%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 70.60B | 69.62B | 68.35B | 66.72B | 64.97B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 70.60B | 69.62B | 68.35B | 66.72B | 64.97B |
Cost of Revenue | 41.93B | 41.37B | 40.82B | 40.26B | 39.39B |
Gross Profit | 28.68B | 28.25B | 27.52B | 26.46B | 25.58B |
SG&A Expenses | 1.05B | 994.00M | 994.00M | 994.00M | 994.00M |
Depreciation & Amortization | 3.31B | 3.25B | 3.17B | 3.12B | 3.08B |
Other Operating Expenses | 13.77B | 13.51B | 13.17B | 12.59B | 11.88B |
Total Operating Expenses | 60.06B | 59.12B | 58.16B | 56.96B | 55.34B |
Operating Income | 10.55B | 10.50B | 10.18B | 9.75B | 9.63B |
Income Before Tax | 8.52B | 8.74B | 8.46B | 8.03B | 7.71B |
Income Tax Expenses | 1.87B | 1.90B | 1.83B | 1.68B | 1.62B |
Earnings from Continuing Operations | 6.66K | 6.83K | 6.63K | 6.35K | 6.09K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -897.00M | -903.00M | -887.00M | -880.00M | -849.00M |
Net Income | 5.76B | 5.93B | 5.74B | 5.47B | 5.24B |
EBIT | 10.55B | 10.50B | 10.18B | 9.75B | 9.63B |
EBITDA | 13.86B | 13.75B | 13.36B | 12.87B | 12.70B |
EPS Basic | 22.19 | 22.48 | 21.52 | 20.27 | 19.17 |
Normalized Basic EPS | 17.05 | 16.77 | 15.98 | 14.84 | 14.52 |
EPS Diluted | 21.97 | 22.27 | 21.30 | 20.06 | 18.98 |
Normalized Diluted EPS | 16.90 | 16.62 | 15.83 | 14.69 | 14.38 |
Average Basic Shares Outstanding | 1.04B | 1.05B | 1.07B | 1.08B | 1.09B |
Average Diluted Shares Outstanding | 1.05B | 1.06B | 1.08B | 1.09B | 1.11B |
Dividend Per Share | 2.64 | 2.58 | 2.52 | 2.46 | 2.40 |
Payout Ratio | 11.98% | 11.55% | 11.82% | 12.27% | 12.61% |